electroCore, Inc. Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross
electroCore, Inc. (ECOR) reported Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross of $826.92 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross · last filed 2020-03-30
- electroCore, Inc. research and development arrangement, contract to perform for others, costs incurred, gross for the quarter ending 2019-06-30 was $328.73K.
- electroCore, Inc. research and development arrangement, contract to perform for others, costs incurred, gross for the quarter ending 2019-03-31 was $498.19K.
- electroCore, Inc. research and development arrangement, contract to perform for others, costs incurred, gross for the quarter ending 2018-12-31 was $395.50K.
- electroCore, Inc. research and development arrangement, contract to perform for others, costs incurred, gross for fiscal 2019 was $826.92K, a 109.13% increase from fiscal 2018.
- electroCore, Inc. research and development arrangement, contract to perform for others, costs incurred, gross for fiscal 2018 was $395.40K.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 3 month | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 3 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 6 month | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 6 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 9 month | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 12 month |
|---|---|---|---|---|---|---|
| 2019-12-31 | $826.92K 10-K · filed 2020-03-30 | |||||
| 2019-06-30 | $328.73K 10-Q · filed 2019-08-14 | $826.82K 10-Q · filed 2019-11-14 | $826.92K 10-Q · filed 2019-08-14 | $1.22M derived: sum of 3 quarters · filed 2019-11-14 | ||
| 2019-03-31 | $498.19K 10-Q · filed 2019-05-15 | $893.70K derived: sum of 2 quarters · filed 2019-11-14 | ||||
| 2018-12-31 | $395.50K 10-Q · filed 2019-11-14 | $395.40K 10-Q · filed 2019-05-15 | $395.40K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |